Vitro Biopharma, Inc. — Form D/A
Vitro Biopharma, Inc. of GOLDEN, CO, a company, filed a Form D amendment with the SEC on 2020-10-08. The offering totals $3.5M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-10-08
- Form: D/A
- Accession: 0001011034-20-000026
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $1.0M
- Remaining: $2.5M
- Investors: 10
- Date of first sale: 2020-01-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-358825
Issuer
- Name: Vitro Biopharma, Inc.
- CIK: 0000793171
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 4621 TECHNOLOGY DR., GOLDEN, CO, 80403
- Phone: 866-848-7627
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| John Evans | Executive Officer | West Haven, CT |
| John Packs | Director | Golden, CO |
| James Musick | Director | Golden, CO |
| James Musick | Executive Officer | Golden, CO |
| Thomas Ohrt | Executive Officer | Golden, CO |
| Chris Furman | Director | Golden, CO |
| Chris Furman | Executive Officer | Golden, CO |
| Caroline Mosessian | Director | Golden, CO |
| Tiana R States | Executive Officer | Denver, CO |
| Nathan Haas | Executive Officer | Denver, CO |
| Christopher Furman | Director | Denver, CO |
| Christopher Furman | Executive Officer | Denver, CO |
| John R Packs | Director | Denver, CO |
| James R Musick | Director | Denver, CO |
| James R Musick | Executive Officer | Denver, CO |
| Caroline R Mosessian | Director | Denver, CO |
| Caroline R Mosessian | Executive Officer | Denver, CO |
| JACK ZAMORA | Director | DENVER, CO |
| JACK ZAMORA | Executive Officer | DENVER, CO |
| John Evans | Director | West Haven, CT |
| ERIK D VAN HORN | Director | Golden, CO |
| ERIK D VAN HORN | Executive Officer | Golden, CO |
| ERIK VAN HORN | Director | GOLDEN, CO |
Other filings by this issuer (8)
More